Literature DB >> 12717086

The nature of colitis in chronic granulomatous disease.

Michela G Schäppi1, Nigel J Klein, Keith J Lindley, Dyanne Rampling, Virpi V Smith, David Goldblatt, Peter J Milla.   

Abstract

BACKGROUND: Patients with chronic granulomatous disease (CGD) may have gastrointestinal manifestations, commonly colitis. The etiology, prevalence, and inflammatory process of CGD colitis are unclear.
OBJECTIVES: To characterize the inflammatory process of CGD colitis and to compare it with other inflammatory bowel disorders.
METHODS: Colonic mucosal biopsies from 8 CGD patients were immunostained for eosinophils, neutrophils, macrophages, and adhesion molecules (ICAM; VCAM, E-selectin) and compared with normal and diseased controls (allergic colitis, ulcerative colitis, and melanosis coli). Cell types were counted and expressed as cell/mm2.
RESULTS: The inflammatory infiltrate in CGD colitis differed from the normal controls by an increase in eosinophils (110; 48-176 [median and range] versus 14.5; 3-30; P < 0.005) and macrophages (291.5; 203-480 versus 38.5; 27-64; P < 0.005). There was a paucity of neutrophils compared to ulcerative colitis (10; 0-101 versus 315.5; 78-688; P < 0.005). Expression of HLA-DR was increased in the epithelium and vascular endothelium in CGD compared with normal controls. Patterns of expression of the adhesion molecules differed significantly in CGD from those in other inflammatory bowel diseases: intracellular adhesion molecule-1 was more strongly expressed in the lamina propria, vascular adhesion molecule-1 was more patchily expressed, and E-selectin was present only in the small vessels.
CONCLUSIONS: The mechanism of inflammation and profile of inflammatory mediators in CGD colitis differs from that in other inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717086     DOI: 10.1097/00005176-200305000-00006

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  19 in total

1.  Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients.

Authors:  Meghna Alimchandani; Jin-Ping Lai; Phyu Phyu Aung; Sajneet Khangura; Natasha Kamal; John I Gallin; Steven M Holland; Harry L Malech; Theo Heller; Markku Miettinen; Martha M Quezado
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

Review 2.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

Review 3.  Neutrophils and inflammatory metabolism in antimicrobial functions of the mucosa.

Authors:  Eric L Campbell; Sean P Colgan
Journal:  J Leukoc Biol       Date:  2015-02-24       Impact factor: 4.962

4.  Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis.

Authors:  Gulbu Uzel; Jordan S Orange; Nina Poliak; Beatriz E Marciano; Theo Heller; Steven M Holland
Journal:  Clin Infect Dis       Date:  2010-11-08       Impact factor: 9.079

Review 5.  Host-microbiota interactions in inflammatory bowel disease.

Authors:  Roberta Caruso; Bernard C Lo; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2020-01-31       Impact factor: 53.106

6.  Utility of screening for chronic granulomatous disease in patients with inflammatory bowel disease.

Authors:  Preeti Jaggi; Rebecca Scherzer; Rose Knieper; Hayat Mousa; Vinay Prasad
Journal:  J Clin Immunol       Date:  2011-11-17       Impact factor: 8.317

Review 7.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

8.  High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease.

Authors:  Joyce E Yu; Suk See De Ravin; Gulbu Uzel; Carol Landers; Stephan Targan; Harry L Malech; Steven M Holland; Wenqing Cao; Noam Harpaz; Lloyd Mayer; Charlotte Cunningham-Rundles
Journal:  Clin Immunol       Date:  2010-10-16       Impact factor: 3.969

9.  Severe and Rapid Progression in Very Early-Onset Chronic Granulomatous Disease-Associated Colitis.

Authors:  Toshinao Kawai; Katsuhiro Arai; Shizuko Harayama; Yumiko Nakazawa; Fumihiro Goto; Takanobu Maekawa; Eiichiro Tamura; Toru Uchiyama; Masafumi Onodera
Journal:  J Clin Immunol       Date:  2015-08-02       Impact factor: 8.317

10.  The role of surgery in the management of patients with refractory chronic granulomatous disease colitis.

Authors:  Melissa M Alvarez-Downing; Natasha Kamal; Suzanne M Inchauste; Sajneet K Khangura; Harry L Malech; Steven M Holland; Marybeth S Hughes; Theo Heller; Richard M Sherry
Journal:  Dis Colon Rectum       Date:  2013-05       Impact factor: 4.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.